In summary, suppression of GBM tumor growth correlated with reduction of immune suppressive cells (Treg and MDSC), an increase of tumor killing macrophages (M1), and reduction of markers of chronic inflammation (CCL4 and IFNγ) in the tumor microenvironment. Here, CCL4 is linked to glioblastoma.